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T he elbow joint is affected in 25-53% of patients with rheumatoid arthritis (RA) [1].  Total elbow 
arthroplasty (TEA) has been a reliable procedure for 
reconstruction of severely damaged RA elbows,  and 
acceptable implant survivals have been reported in both 
linked and unlinked elbow prostheses [2-9].
We recently reported the favorable clinical results of 
alumina ceramic TEA with the stemmed Kyocera-type I 
(SKC-I) prosthesis for patients with RA.  When SKC-I is 
implanted with bone cement,  the survival rate of the 
prosthesis for up to 20 years is 92.6% or 86.3% with 
loosening or implant revision defined as end points,  
respectively [10].  The J-alumina ceramic elbow (JACE;  
Kyocera Medical Co.,  Osaka,  Japan) is an alumina 
ceramic elbow prosthesis that was introduced for clini-
cal application in 1997.  The implant design was subse-
quently changed based on the short- to medium-term 
clinical results obtained with the SKC-I prosthesis.  The 
humeral sapphire stem and ulnar ceramic stem were 
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We investigated the long-term clinical results of total elbow arthroplasty (TEA) by cementless fixation of alu-
mina ceramic unlinked elbow prostheses (J-alumina ceramic elbows: JACE) for the reconstruction of elbow 
joints with rheumatoid arthritis (RA).  Seventeen elbows in 17 patients (aged 44-72 years,  average 54.8) 
replaced by JACE TEA without bone cement were investigated.  The average follow-up period was 10.7 (range,  
1.0-19.3) years.  Clinical conditions of each elbow before and after surgery were assessed according to the Mayo 
Elbow Performance Index (MEPI).  Radiographic loosening was defined as a progressive radiolucent line of 
more than 1 mm that was completely circumferential around the intramedullary stem.  The average MEPI sig-
nificantly improved from 46.8 points preoperatively to 66.8 points at final follow-up (p= 0.0226).  However,  
aseptic loosening was noted in 10 of 17 elbows (58.8%) and revision surgery was required in 7 (41.2%).  Most 
loosening was observed on the humeral side.  With radiographic loosening and revision surgery defined as the 
end points,  the likelihoods of prosthesis survival were 41.2% and 51.8%,  respectively,  up to 15 years by 
Kaplan-Meier analysis.  The clinical results of JACE implantation without bone cement were disappointing,  
with high revision and loosening rates of the humeral component.
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abolished,  and exchanged for a titanium (Ti) stem 
coated by arc plasma deposition,  with the expectation 
that cementless fixation of the components would be 
employed (Fig. 1).  Between 1997 and 2000,  the 
cementless-type JACE was used for all RA elbows with-
out bone cement.  In the current retrospective study,  we 
reviewed the long-term clinical results of JACE TEA.
Patients and Methods
The current retrospective study was approved by the 
Ethics Committee of our institute (No. 576).  All 
patients met the American Rheumatism Association 
1987 revised criteria for RA [11].  Twenty-two elbows of 
22 RA patients underwent primary TEA with a JACE 
prosthesis at our institute and affiliated hospitals from 
1997 to 2000.  Three patients (3 elbows) died before the 
minimum 2-year follow-up of causes unrelated to the 
surgery and were excluded from the analysis.  Two 
elbows (two patients) who underwent “hybrid” fixation 
(cementless fixation of the humeral component and 
cemented fixation of the ulnar component) were also 
excluded from the analysis.  As a result,  17 elbows in 17 
patients (17 women,  aged 44-71,  mean age 55.8 years) 
were enrolled in the current study.  One surgeon (H.I.) 
implanted 16 prostheses in 16 elbows; the other sur-
geon (K.N.) implanted the remaining prosthesis in one 
elbow.  Three patients (3 elbows) died during the study 
period after more than 2 years of follow-up,  and their 
records at the final visit were used for analysis.  In 
patients who underwent revision surgery,  clinical data 
just before the revision surgery were used as the data of 
the final follow-up.  The mean follow-up period was 
10.7 (range 1.0-19.3) years (Table 1).  Resection of the 
distal ulnar end (Darrach procedure) was combined 
with TEA in patients with wrist joint deterioration of 
Larsen’s grade III or IV,  to improve the pain at the distal 
radio-ulnar joint,  and forearm rotation [10].
The clinical condition of each elbow before and after 
surgery was assessed according to the Mayo Elbow 
Performance Index (MEPI; 0-100 points) [12].  On the 
basis of this system,  the overall results were defined as 
excellent (> 89),  good (75-89),  fair (60-74),  and poor 
( < 60).  Radiographic loosening was defined as a pro-
gressive radiolucent line of more than 1 mm in the cir-
cumferential direction around the intramedullary stem 
[13].
Statistical analysis. Statistical analysis was per-
formed by the Wilcoxon signed rank test to compare 
pre- and post-operative data.  For survival analysis for 
revision surgery including implant removal,  with or 
without reinsertion of a new implant,  the period 
between the initial surgery and revision surgery was 
used for Kaplan-Meier analysis.  All analyses were con-
ducted using Prism software (version 5.0a; Graph-Pad 
Software,  San Diego,  CA,  USA) with a value of p< 0.05 
regarded as significant.
Results
Darrach’s procedure was simultaneously combined 
with TEA in 4 cases (4 wrists) for patients with restricted 
forearm rotation.  Results of the clinical assessment with 
MEPI are summarized in Table 1.  At the final fol-
low-up,  pain scores improved significantly from 18.5 
(range 0-45) points preoperatively to 30.0 (range 0-45) 
points postoperatively (p = 0.0165),  but 6 patients (6 
elbows) had moderate to severe pain.  Scores for range 
of motion were 15.1 (range 5-20) points preoperatively 
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Fig. 1　 Photographs of cementless-type JACE prostheses (pros-
theses for the left elbow).  The humeral and ulnar components 
consist of a solid ceramic trochlea and high-density polyethylene,  
respectively,  with an intramedullary Ti stem.  The stem of the 
humeral component is 60 mm in length and 8 mm in diameter,  and 
the ceramic trochlea has two width options (28 and 30 mm).  The 
width of the ulnar surface is 20 mm,  and the stem of the ulnar com-
ponent has two thickness options (10 and 12 mm).
and 14.7 (range 5-20) points postoperatively.  Preopera-
tive and postoperative motion arcs were 78 and 81 
degrees in flexion/extension,  and 118 and 147 degrees 
in pronation/supination,  respectively (Table 2).  Preop-
erative and postoperative stability scores were 5.9 
(range,  0-10) and 6.8 (range,  1-10),  and function 
scores were 7.1 (range,  0-25) and 15.3 (range,  0-25),  
respectively.  MEPI scores were significantly improved 
from 46.8 (range,  20-80) points preoperatively to 66.8 
(range,  30-100) points postoperatively (p = 0.0226).  
Overall results were good in 2,  fair in 2,  and poor in 13 
elbows preoperatively,  and excellent in 7,  good in 2,  
and poor in 8 postoperatively (Supplemental Table).
Although 10 of 17 elbows were still in situ at the final 
follow-up (Fig. 2),  complications were noted in 11 
elbows in 11 patients (64.7%).  An intraoperative 
humeral fracture was noted in 2 elbows,  and both 
elbow fractures were healed conservatively.  However,  
ulnar neuritis occurred in one of 2 elbows,  and 
required ulnar nerve release.  Up to the final follow-up,  
10 of 17 elbows (58.8%) showed radiographic loosening.  
The average period before identification of loosening 
was 1.5 ± 0.9 years after surgery.  Of these cases,  one 
patient died for reasons unrelated to the surgery,  and 2 
patients declined surgery because the loosening did not 
cause elbow joint instability or pain during the fol-
low-up period.  Seven elbows (41.2%) showed progres-
sive loosening around the humeral stem (Fig. 3),  and 
required revision surgery with implant removal at an 
average of 7 ± 3.7 years after surgery.  Of these,  5 
humeral components were revised using a cemented 
humeral component with or without a long stem.  One 
elbow also showed loosening of the ulnar component,  
and was replaced using a thick ulnar component with 
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Table 1　 Results of clinical assessment
Pre-op. Post-op. P＊
Pain (no. of elbows)
　　None 1 8
　　Mild 6 3
　　Moderate 6 4
　　Severe 4 2
Pain score (mean,  range) 18.5 (0-45) 30.0 (0-45) 0.0165＊
ROM (no. of elbows)
　　Arc＞100 degrees 3 5
　　Arc 50 to 100 degrees 13 8
　　Arc＜50 degrees 1 3
ROM score (mean,  range) 15.1 (5-20) 14.7 (5-20) 0.6788　
Stability (no. of elbows)
　　Stable 4 10
　　Moderately unstable 12 3
　　Grossly unstable 1 4
Stability score (mean,  range) 5.9 (0-10) 6.8 (0-10) 0.5071　
Function score (mean,  range) 7.1 (0-25) 15.3 (0-25) 0.0201＊
Mayo Elbow Performance Index (mean,  range) 46.8 (20-80) 66.8 (30-100) 0.0226＊
Overall results (no.) (Excellent/good/fair/poor) 0/2/2/13 7/2/0/8
ROM: range of motion.
＊Wilcoxon signed rank test to compare the pre- and post operative data.  P＜0.05 regarded as signiﬁcant.
Table 2　 Pre- and Post-operative range of motion after JACE 
TEA without cement ﬁxation
Direction
Range of motion (degrees)
Pre-op. Post-op.
Flexion 111 (75-135) 118 (90-140)
Flexion contracture 33 (0-70) 37 (0-70)
Flexion/extension arc 78 (40-120) 81 (35-120)
Pronation 63 (20-90) 68 (15-90)
Supination 55 (0-90) 79 (30-90)
Pronation/supination arc 118 (30-180) 147 (75-180)
Average (range)
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bone cement,  whereas no loosening was noted around 
the ulnar component of the other 3 elbows.  The 
remaining 2 elbows were replaced using linked elbow 
prostheses (Coonrad-Morrey [12] and PROSNAP [14]).  
With loosening and revision as the end points,  Kaplan-
Meier analysis resulted in survival rates for the cement-
less prosthesis of 41.2% and 51.8%,  respectively,  for up 
to 15 years (Fig. 4).
Discussion
The alumina ceramic elbow prosthesis was first 
designed in the late 1970s,  based on a measurement 
study of Japanese cadaveric elbows [15].  The design of 
the implant was an unlinked surface replacement pros-
thesis using polycrystalline alumina ceramic as a solid 
trochlea on high-density polyethylene (Kyocera-type I) 
[16].  In 1986,  the first model change was made to an 
unlinked stemmed type-type (SKC-I); however,  8 
elbows implanted without cement fixation showed early 
tilt or subsidence of the humeral component.  When 
used with bone cement fixation,  SKC-I showed excel-
lent mid- to long-term clinical outcomes [10].
There is still debate regarding possible advantages 
and disadvantages of cemented and cementless fixation 
of the joint prosthesis in terms of ease of revision,  com-
plications of cementing,  and long-term survival of the 
prosthesis [17].  JACE is the third-generation alumina 
ceramic elbow after SKC-I,  and was developed with the 
expectation of cementless fixation of the prosthesis.  
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Fig. 2　 Anteroposterior (A,  C,  E) and lateral (B,  D,  F) radiographs of the right elbow of a 56-year-old woman before surgery (A,  B),  
at the time of surgery (C,  D) and 19 years after cementless ﬁxation of JACE (E,  F).  A medial epicondyle fracture of the humerus occurred 
intra-operatively,  and bone union was obtained with conservative treatment.  No loosening is seen around either the humeral or ulnar com-
ponent.  MEPI improved from 35 to 94 points at the ﬁnal follow-up.
Tachihara et al.  reported favorable early clinical results 
of JACE prosthesis in 34 RA elbows,  but found loosen-
ing in 5 elbows (15%) [18].  The current study showed 
disappointing long-term clinical results of cementless 
JACE,  with a revision rate of 41.2%.  This is consider-
ably higher than the revision rate of TEA in RA patients 
reported in the systematic review by Little et al.  [7].  The 
main reason for revision surgery was implant loosening 
(58.8%),  and the survival rate at 15 years was 41.2% 
when loosening was defined as the end point.  The pos-
sible factors affecting loosening might include patients’ 
bone quality,  the design of the prosthesis (a solid troch-
lea,  a short and relatively thin stem for the patient’s 
humeral diameter),  and stress loaded by the shoulder 
and wrist joints with restricted range of motion in RA 
patients.  Most loosening was observed on the humeral 
side with the tip of the components displaced anteriorly 
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Fig. 4　 Kaplan-Meier survivorship curves for cementless 
JACE; loosening (dotted line) and revision (solid line) with implant 
removal are used as end points.
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Fig. 3　 Anteroposterior (A,  C,  E) and lateral (B,  D,  F) radiographs of the right elbow of a 55-year-old woman before surgery (A,  B),  
and at 3 weeks (C,  D) and 10 years after cementless ﬁxation of the JACE (E,  F).  Loosening is seen around the humeral component with 
anterior tilting of the stem and subsidence of the component.  The MEPI before the revision surgery was 42 points.
and articulation displaced posteriorly,  accompanied by 
subsidence of the component,  similar to the loosening 
pattern of the Souter-Strathclyde prosthesis [19].  In the 
English literature,  the Kudo prosthesis is the only 
unlinked elbow in which cementless fixation succeeded 
[20].  In addition to component stabilization with the 
intramedullary stem,  the round-cap structure of the 
humeral component holds the distal humerus.  Because 
the solid trochlea seen in the JACE and Souter-
Strathclyde prostheses does not resist the predomi-
nantly posteriorly-directed forces during flexion–
extension,  the intramedullary stem is the only structure 
that stabilizes the humeral component of the JACE 
prosthesis.  The stem of the humeral component (60 mm 
length and 8 mm diameter) might not be sufficient for 
intramedullary fixation when used for osteoporotic 
patients without bone cement,  and might need varia-
tion in length and thickness.
In conclusion,  cementless implantation results in a 
high complication rate with loosening of the humeral 
component and a high revision rate.  Although the 
cementless-type JACE is still on the market,  we no lon-
ger use this type of JACE,  and the cemented-type is now 
standard for the reconstruction of RA elbows.
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